Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

NCT03168828 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurogenic Detrusor Overactivity

Interventions

DRUG: Trospium-Releasing Intravesical System (TAR-302-5018)

Sponsor

Taris Biomedical LLC